Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 656

1.

Metastatic neuroendocrine hepatic tumors: resection improves survival.

Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.

Arch Surg. 2006 Oct;141(10):1000-4; discussion 1005.

PMID:
17043278
2.

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.

Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC.

Cancer. 2005 Oct 15;104(8):1590-602.

3.

Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.

Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, Murthy R, Hicks ME, Ajani JA.

Cancer J. 2003 Jul-Aug;9(4):261-7.

PMID:
12967136
4.

Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.

Osborne DA, Zervos EE, Strosberg J, Boe BA, Malafa M, Rosemurgy AS, Yeatman TJ, Carey L, Duhaine L, Kvols LK.

Ann Surg Oncol. 2006 Apr;13(4):572-81. Epub 2006 Feb 28. Erratum in: Ann Surg Oncol. 2006 Aug;13(8):1162. Strosberg, Jonathon [corrected to Strosberg, Jonathan].

PMID:
16511671
5.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
6.

Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.

Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J, Benson AB, Rao S, Joehl RJ.

Surgery. 2001 Oct;130(4):677-82; discussion 682-5.

PMID:
11602899
7.

Hepatic neuroendocrine metastases: does intervention alter outcomes?

Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y, Blumgart LH.

J Am Coll Surg. 2000 Apr;190(4):432-45.

PMID:
10757381
8.

Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms.

Brown KT, Koh BY, Brody LA, Getrajdman GI, Susman J, Fong Y, Blumgart LH.

J Vasc Interv Radiol. 1999 Apr;10(4):397-403.

PMID:
10229465
9.

Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver.

Pawlik TM, Vauthey JN, Abdalla EK, Pollock RE, Ellis LM, Curley SA.

Arch Surg. 2006 Jun;141(6):537-43; discussion 543-4.

PMID:
16785353
10.

The management of patients with advanced carcinoid tumors and islet cell carcinomas.

Moertel CG, Johnson CM, McKusick MA, Martin JK Jr, Nagorney DM, Kvols LK, Rubin J, Kunselman S.

Ann Intern Med. 1994 Feb 15;120(4):302-9.

PMID:
8291824
11.

Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.

Christante D, Pommier S, Givi B, Pommier R.

Surgery. 2008 Dec;144(6):885-93; discussion 893-4. doi: 10.1016/j.surg.2008.08.037.

PMID:
19040993
12.

Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.

Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H; Kagoshima Liver Cancer Study Group.

J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.

PMID:
19300896
13.

Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer.

Kornprat P, Jarnagin WR, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M.

Arch Surg. 2007 Nov;142(11):1087-92.

PMID:
18025338
14.

Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.

Clouse ME, Perry L, Stuart K, Stokes KR.

Digestion. 1994;55 Suppl 3:92-7.

PMID:
7698544
15.

Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.

Chung MH, Pisegna J, Spirt M, Giuliano AE, Ye W, Ramming KP, Bilchik AJ.

Surgery. 2001 Dec;130(6):954-62.

PMID:
11742323
16.

Overview: the management of metastatic carcinoid tumors.

Ramage JK, Catnach SM, Williams R.

Liver Transpl Surg. 1995 Mar;1(2):107-10. Review.

17.

The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.

Chambers AJ, Pasieka JL, Dixon E, Rorstad O.

Surgery. 2008 Oct;144(4):645-51; discussion 651-3. doi: 10.1016/j.surg.2008.06.008.

PMID:
18847650
18.

Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.

Ho AS, Picus J, Darcy MD, Tan B, Gould JE, Pilgram TK, Brown DB.

AJR Am J Roentgenol. 2007 May;188(5):1201-7.

PMID:
17449759
19.

Management of hepatic metastasis of gastrointestinal carcinoid tumors.

Landry CS, Scoggins CR, McMasters KM, Martin RC 2nd.

J Surg Oncol. 2008 Mar 1;97(3):253-8. doi: 10.1002/jso.20957.

PMID:
18264984
20.

Hepatic resection for metastatic neuroendocrine carcinomas.

Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK.

Am J Surg. 1995 Jan;169(1):36-42; discussion 42-3.

PMID:
7817996

Supplemental Content

Support Center